As a healthcare professional, I would focus on finding treatments for the strains of HPV that were categorized as the most high-risk. These high-risk strains include HPVs 16, 18, 31 and 45 because they are found in approximately 80% of all cervical cancers. Since there are already vaccines for HPVs 16 and 18, focusing on HPVs 31 and 45 would be a good start. Other strains that aren’t as high risk, but are still considered possibly carcinogenic are HPVs 33, 35, 39, 51, 52, 56, 58, and 59.
Since HPV is a sexually transmitted disease, it would be best to administer these vaccines to children before they become sexually active. Vaccines that are already being administered currently cost around $130/ shot. I believe that this is a fair price (without insurance) and should be the goal price for other vaccines that are being made.
